An analysis, by means of varying gene dosage at the tetraploid level, of the kinetic relationships which link the activity of individual enzymes to the functioning of the entire arginine biosynthetic pathway is presented. Tetraploid gene dosage series were prepared for each of the following gene-enzyme pairs: argB coding for acetylglutamate kinase, argF for ornithine transcarbamylase, argH for argininosuccinase and cpaI coding for one of the two polypeptidic constituents of the argininepat hway-specific carbamoylp hosphate synt hetase.
I N T R O D U C T I O N
While studying the regulatory behaviour of a specific metabolic pathway, there is always the problem of the actual catalytic activities in vivo of the individual enzymes of that pathway. The activities of the enzymes in their native milieu cannot be inferred from assays in vitro, as they are usually performed. The problem becomes really crucial if one is dealing with a metabolic system like that of arginine biosynthesis in Saccharomyces cerevisiae, i.e. a set of eight known reactions which are determined by I I structural genes which are largely scattered over the genome and the expression of which appears to lack coordination (Minet, 1971 ; Wiame, 1972) .
First one may ask what is the rate-limiting step of the arginine biosynthetic sequence. One would expect the position of the pace-maker enzyme within the pathway to be at the starting point of the sequence, where it could operate as a valve determining the flux through the entire circuit. If this enzyme had allosteric properties, allowing feed-back inhibition and possibly activation, it would allow an efficient regulation of the pathway. Second, what about the enzymes which do not mediate rate-limiting steps? To what extent are these enzymes in excess and, if the excess is large, what may be the physiological meaning of this?
It is the main topic of the present and another forthcoming paper to investigate these questions. The tool employed is gene dosage at the tetraploid level. For each structural gene of the arginine biosynthetic pathway (the arg-genes) a tetraploid gene dosage series is prepared and genetically checked according to the procedures described previously (Hilger, I 973) . Each series comprizes four strains which, for a given allelic pair arg+/arg-, or + / -, represent the following gene doses: 4/4 (wild-type, + + + +), 3/4 (triplex, + + + -), 2/4 (duplex, + + --) and 1/4 (simplex, + ----). If the mutant allele, arg-, is inactive, then the series provides a system of four gene concentrations decreasing linearly from the normal level (wild-type) to one-fourth of this (simplex). Measurement of the activities in vitro of particular enzymes of the arginine pathway through such systems should allow recognition of the kinetic roles of the individual enzymes in the sequence. Consider, for instance, a gene-enzyme pair determining a rate-limiting step of the arginine biosynthetic pathway. A decrease of the concentration of the gene will entail a lowering of the pool of the end product, arginine, and consequently a regulatory adjustment. The level of the enzyme considered, as well as that of the other arginine pathway enzymes, will show derepression, if they are under arginine control. In contrast, the concentration of a gene coding for a nonrate-limiting enzyme may decrease to a certain extent without resulting in derepression. The amount to which the non-rate-limiting enzyme may be decreased without derepression would be a good measure of the excess of this enzyme over that necessary for normal arginine synthesis.
This study deals with four enzymes, belonging to the three classes into which the arginine pathway enzymes of Saccharomyces cerrvisiae are presently ranged (Minet, I 9-71 ; Wiame, 1972) : (i) acetylglutamate kinase (EC. 2.7.2.3 .) and ornithine transcarbamylase (EC. 2. I .3.3. ) coded by the genes argB and argF, respectively, and belonging to the class of enzymes which are repressible by exogenous arginine in wild-type and non-repressible in argR mutants (BCchet, Grenson & Wiame, I 970; Minet, 1971) ; (ii) the carbamoylphosphate synthetase involved in the arginine pathway and coded by the genes cpaI and cpaII (another carbamoylphosphate synthetase operates in the pyrimidine nucleotide synthesis and is coded by the gene cpu). This enzyme is repressible by exogenous arginine, insensitive to argR mutations, but sensitive to cpaR and typal0 mutations (Lacroute, PiCrard, Grenson & Wiame, 1965 ; Thuriaux, Ramos, Pihard, Grenson & Wiame, 1972) ; (iii) argininosuccinase (EC. 4.3.2. I .), coded by the gene argH and belonging to the class of enzymes which are insensitive to exogenous supplies of arginine.
METHODS
Strains and genetic nzetlzods. The primary, isogenic haploid strains used to build up the tetraploid series were the following: CI1278b = a, wild-type; 3962c = a, wild type; ~~7 9 0 = a, argB-; ~~6 7 6 = SI, argF-; MG542 = 2, argH-; 60284 = a, cpal--2, cpu--2; BJ102 = cc, argRI--2. The auxotrophic strains were selected for loss of enzymatic activities. More detailed informations about these strains and about the rules of nomenclature applied may be found in Grenson, Mousset, Wiame & BCchet (1966) , BCchet et al. (I970) , Wiame (1972) , Hilger (1973) .
The tetraploid clones were developed and analysed according to the procedure outlined in the accompanying paper by Hilger. The following five tetraploid series were prepared: one argB series (acetylglutamate kinase); two argF series (ornithine transcarbamylase), one with the dose 4/4 for the gene argRI+, the other with argRZf at dose 0/4 (the synthesis of the arg-enzymes of class I (see Introduction) in the four strains of the latter series thus escapes repression by arginine); one argH series (argininosuccinase); one cpaZ series, the four members of which had the dose 0/4 for cpu-in order to avoid a possible interference of the product of cpuf (carbamoylphosphate synthetase integrated in the pyrimidine pathway) with the cpal dosage effects to be measured; the deficiency resulting in this latter series from the elimination of cpirf was compensated for by supplementing the media with uracil All the clones used in this investigation had their genotypes confirmed by genetic analysis. Media, conditions and rneasiirement of growth. The gene dosage effects were measured on cells developing exponentially in liquid minimal medium no. 149 (Lacroute et a/. 1965; Grenson et al. 1966) . The members of the cpal series were grown in the same medium supplemented with uracil ( I 00 pglml).
The incubation temperature was 29 "C and the cultures were grown aerobically on a rotatory shaker; growth rates were established by measuring the absorbance at 660 nm in a Beckman spectrophotometer, model B.
(100 pglml).
Eiizynie ussajqs
Ornitliiiir transcarbamylase was measured according to the method described by Ramos, Thuriaux, Wiame & Bkchet (1970) .
Carbatiiol*/pliosphate synthetase was assayed by a modification of the method described by Lacroute et a/. (1965) . Cells grown under the conditions described above were resuspended in 0.02 M-imidazole buffer (pH 7*5), containing 0.5 mM-Magnesium-Titriplex 0, and crushed in a French pressure cell modified as described by Walters & Stahly (1968) . After centrifuging the extract at 250008 for 5 min, the supernatant fluid was dialysed by treatment on a column of Sephadex @ G25 (pretreated with the same buffer). Carbamoylphosphate synthetase activities were determined shortly after the preparation of the extract in order to reduce the loss caused by the great instability of the enzyme. Carbamoylphosphate synthetase activity was assayed by converting [14C]bicarbonate to [14C]citrulline in the presence of an excess of ornithine transcarbamylase. Incubations were performed at 30 "C for 30 min and contained the following in a volume of I ml: ATP, 10 pmol; MgCL, 12 pmol; glutamine, 10 pmol; 14C-KHC0, (0.1 to 0-2 pCi/pmol), 10 pmol; ornithine, 5 pmol; KCI, 10 pmol ; imidazole buffer (pH 7.9, 60 pmol; partially purified ornithine transcarbamylase from Escherichia coli, IOO to 200 units. The reaction was stopped by the addition of I ml of cold 0.25 M-trichloroacetic acid and the precipitated proteins were removed by centrifugation. After elimination of the excess 14C-KHC03 by air bubbling, a sample of I ml of the incubated mixture was transferred to a polyethylene scintillation vial containing 10 ml of scintillation cocktail (4 parts of Triton x 100, 6 parts of a solution containing 0.5% 2,5-diphenyloxazole and I o naphthalene in reagent-grade dioxane). The samples were counted in a model LSroo Beckman liquid scintillation spectrometer with an efficiency of 55%.
Acet~~lglirtarnate kinase can be assayed easily by coupling the synthesis of phospho-Nacetylglutamate with its reduction into the corresponding semi-aldehyde, the concomitant disappearance of NADPH being measured. In this assay the dehydrogenase of the extract is used; it is in excess and increases co-ordinatively with the kinase activity, the genes coding for these two enzymes forming an operon which is also indicated by polarity mutations (Minet, Thuriaux, Grenson & Wiame, unpublished results) . However, that assay method is quantitatively uncertain due to an interfering NADPH oxidizing activity which is present in the extract. A more accurate but more tedious determination which implies a partial purification in order to eliminate an interfering reaction was developed. It proceeds by the determination of energy-rich phosphate by the method of Lipmann & Tuttle (1945) . The procedure was the following: 1.5 g dry weight of cells (corresponding to 2-5 1 culture) were suspended in 20 ml 0.25 M-tris-HCl buffer (pH 7-5) containing 0.5 mwdithiothreitol (DTT) and crushed in a French pressure cell modified according to Walters & Stahly (1968) . The supernatant of the extract was brought to 35 ml with buffer and precipitated with streptomycin sulphate (final concentration I yo). After 15 rnin standing, the precipitate was removed and the supernatant precipitated at 50 %, saturation of ammonium sulphate. The precipitate was discarded and ammonium sulphate was added to 60 yo saturation. The precipitate which contained the enzyme was dissolved in 0.6 ml 0.05 tris-HC1 buffer (pH 7-5) containing 0.5 mM-DTT, and dialysed by filtration through a column containing 3 g Sephadex 0 G25.
The solution obtained, containing 10 to 15 mg protein/ml, was used for the kinase assay. The assay mixture (prepared at o "C) contained: 0.325 ml of extract plus 0.05 M-tris-HCl (pH 7.5) containing 0.5 mM-DTT, 0.1 in1 of M-tris-HCl buffer (pH 7-5), 0.3 ml of freshly prepared 3-3 M-hydroxylamine-HC1 (pH 7.9, 0.075 ml of 0.2 M-ATP (pH 7-5), 0-I ml of 0.3 M-MgCl, and 0.1 ml of 0-8 M-N-a-acetylglutamate (pH 7-5). The reaction was started by transfer to 30 "C and stopped after 90 nnin by addition of 0.33 ml of ~N -H C~ and 0. Argininosuccinate syntlzetase. A 0.15 g dry weight portion of cells (corresponding to 250 ml culture) was suspended in 3 mlo.05 M-potassium phosphate buffer, pH 7-5, sonicated for 8 min in a MSE-Mullard sonic oscillator. The supernatant of the centrifuged extract was dialysed twice for I h against I mM-pot.assium phosphate buffer (pH 7.5). The activity was determined by measuring the disappearance of citrulline in 30 min at 30 "C in a reaction mixture containing: 0.65 ml of extract (about 6 mg of proteins/ml) plus 0.05 M-phosphate buffer (pH 7-5); 0.03 ml of 0.1 M-citrulline; 0.06 ml of 0-2 M-ATP; 0.06 ml of 0.2 M-MgCl,; 0.2 ml of 0.05 M-L-aspartate. The reaction was stopped by addition of I ml of 6:; trichloroacetic acid and the precipitated proteins discarded by centrifuging. Citrulline was estimated by the method of Archibald (1944) . A control containing no aspartate was subtracted. As the relative disappearance of citrulline decreases with the amount of extract incubated, the activities measured were extrapolated to low concentrations of extract.
Argininosuccinase was assayed by coupling with arginase and estimating the urea formed.
A culture of roo ml (0.6 mg dry weightlml) was permeabilized by addition of 2-5 ml of a mixture of nine parts of a fresh solution of nystatine (0.3% in methanol) and one part of cycloheximide solution (0.08 yo in water). Cycloheximide was used in order to inhibit protein synthesis. The permeabilization was carried on at 30 "C with shaking. After 30 min, the cells were cooled, collected by centrifugation and resuspended in 10 ml 0-02 M-phosphate buffer (pH 7-5). An argininosuccinate solution was prepared by dissolving 75 mg barium argininosuccinate in 1.5 ml H20, adding I ml 0.5 M-K,SO, and removing the precipitated BaSO,. A mixture of 5 vol. of this solution plus 2 vol. of I M-potassium phosphate (pH 7.5) and I vol. of I yo arginase (Worthington) was prepared. A 0.2 ml sample of the latter mixture was incubated for 30 min at 37 "C in presence of 0.7 ml of the permeabilized cells suspension and the reaction stopped with I ml of 7-5 : ( , trichloroacetic acid. After centrifuging, samples of the supernatant were assayed for urea by the method of Archibald (1945) . The K, for argininosuccinate is 3.5 mM. Protein determinations were performed by the method of Folin and Ciocalteu (Layne, An enzinie unit is defined as the amount that catalyses the transformation of I pmol 1957) using bovine serum albumin as standard.
substrate in I h. Specific activities are enzyme units/mg of protein.
R E S U L T S
The argF (ornithine transcarhamylase) dosage efects The dosage effects measured through the two parallel argF series, one composed of strains repressible by arginine (4/4 for a r g R l f ) , the other of members insensitive to arginine (0/4 for argRI+), show that the growth rate remains unaffected at the lower argF doses and that the specific activity of ornithine transcarbamylase is proportional to the number of wild-type argFf alleles, i.e. the specific activity of ornithine transcarbamylase/wild-type allele remains constant through each series of gene doses. The results obtained for the two parallel series are in excellent agreement and illustrate what is known about the effects of the argR mutations (Bkchet et al. 1970) : the levels of ornithine transcarbamylase are about twice the normal in the derepressed argR-strains (Table I ; Fig. I ).
The level of ornithine transcarbamylase is correlated with the arginine pool (Ramos et al. 1970) , and this enzyme can be lowered to one-fourth of its normal value without any change in the arginine pool. This is confirmed by the levels of argininosuccinate synthetase in these tetraploids. The level of this enzyme which is under arginine control remains unaffected as the argF-dose is decreased from 4/4 to r/4.
Tlie argH (argininosuccinase) dosage efects
The relation of the generation time and the enzyme levels to the concentration of argH is similar to that for argF. The enzyme coded by argH decreases linearly with the argH dose, while ornithine transcarbamylase, which is used here as an indicator of the regulation of arginine synthesis, remains at the same level (Table 2 ; Fig. 2 ).
Tlw arg B (acetylglutamate k inase) and cpa1 (carharnojilpliosphate sj 'ti thetase)
dosage efects Again the growth rate is unaffected by decreasing the gene dose to one-fourth (Table 2 ; Fig. 3,4) . However, the effects on the enzyme levels are different from those observed for the total activity of OTCase. rig. 4. uosage errects or tne argB+ allele on the levels ot acetylglutamate kinase (AG kinase) and ornithine transcarbamylase (OTCase). Enzyme levels are expressed as specific activities (units/nig protein).
--O-O-,
Total specific activity of AG kinase; -U--O-, specific activity of AG kinase per argB+ allele; -0-0-, total activity of OTCase. previous enzymes. This time, the relations of the total specific activities of the enzymes to the concentrations of their respective wild-type alleles are not simply proportional. The specific activity/wild-type allele increases as the gene dose decreases. At the same time the activity of the control enzyme, ornithine transcarbamylase, increases. This clearly indicates derepression. The derepression is immediate in both instances, since lowering the gene doses by 1/4 (doses 3/4) results in significant increase of the ornithine transcarbamylase level.
y Iph osp h a t e syn t h e tase A and N-ace t y Ig lu t am a t e k in ase respectively, on the level of ornithine transcarbarnylase and on the generation time

D I S C U S S I O N
The data show that for the four genes considered the growth rate remains constant when the gene doses are varied. The four mutations argB-, argF-, argH-and cpal-, selected for complete loss of the respective enzyme activities, are completely recessive. At the molecular level, this situation may be explained in three ways: (i) the wild-type cell, when grown on minimal medium, may overproduce enzymes with respect to the arginine needs of the cell; (ii) derepression of enzyme synthesis might provide a gene dosage compensation mechanism ; (iii) the products of the mutated alleles might recover a certain activity when associated with the normal product by the formation of active hybrid enzymes (Zimmermann, Schmiedt & Ten Berge, 1969) .
Examination of the enzyme data will help in settling this question. Altering the gene dosage can result in two distinct patterns of enzyme activity. First, simple additivity of the enzyme levels as shown by argF and argH. This relation is analogous to those found for iso-1-cytochrome c in fully induced yeast cells (Slonimski, Archer, Perk, Sels & Somlo, 1965) and for tryptophan synthetase, which seems constitutive in yeast (Ciferri, Sora & Tiboni, 1969) . In our case, the output of the metabolic pathway does not change after lowering the levels of the enzymes to one-fourth. This indicates that the two enzymes are not rate-limiting and their level in iivo is at least four times greater than that necessary for normal arginine synthesis. A similar situation is suggested for argininosuccinase in Neurospora crassa (Donachie, I 964).
The second gene dosage pattern is of a more elaborate type. The activities of the argBf and cpalr alleles increase as the gene doses decrease. This results from derepression of the synthesis of the arginine pathway enzjmes, as shown by the control enzyme ornithine transcarbamylase. A gene dosage relation of this kind has been found in yeast by Nelson & Douglas (1963) for the gene-enzyme pair gar-galactokinase (contrary to the statement by Hartwell, 1970). The enzyme data for the various argBf and cpaIf dosages suggest that carbamoylphosphate synthetase and acetylglutamate kinase are rate-limiting enzymes for arginine synthesis in wild-type yeast grown on minimal medium.
The two distinct gene dosage patterns observed imply two distinct kinetic situations, in vivo, with respect to the enzymes involved. Concerning the argF and argH gene dosages, the kinetic situation may be expected to be the following: ornithine transcarbamylaseandargininosuccinase must be far from saturation by their respective substrates, when wild-type yeast cells are grown exponentially on minimal medium; then lowering the levels of each one of the two enzymes considered, by decreasing the corresponding gene concentrations, results in a shift of the substrate pools to higher values; this shift entails an acceleration of the reactions catalysed by ornithine transcarbamylase or argininosuccinase, so that the net flow through the respective reaction steps, and hence the arginine pool, remain approximately constant. In the case of the argB and cpaI genes the kinetic behaviour is completely different: a reduction of the dose of one of these genes results in derepression of the corresponding enzyme as well as in gratuitous derepression of another enzyme of the pathway, ornithine transcarbamylase, which was previously shown as non-limiting. Such a behaviour could result from one of the two following siluations: (i) the enzyme of which the gene dose is varied functions at its maximal rate; (ii) the cellular concentration of the substrates of this enzyme cannot undergo substantial variations. The latter situation is likely to exist for the enzymes considered here, carbamoylphosphate synthetase and acetylglutamate kinase, in view of the fact that they catalyse the first specific steps of the pathway and, consequently, use substrates, such as ATP, glutamine or HCO-3, which are of general use in the cell.
The pacemaker enzymes acetylglutamate kinase and carbamoylphosphate synthetase are located precisely at the two entries of the arginine biosynthetic pathway. Furthermore, these two enzymes are subjected to feedback controls by arginine-carbamoylphosphate synthetase to repression and acetylglutamate kinase to repression and inhibition (De Deken, 1962; Minet, 1971) . Consequently, the flow of intermediates leading to arginine is governed at the starting points of the reaction sequence and the enzymes located beyond these entries function at the velocity imposed upon them by the pacemakers. This state of things is obviously favourable for the economy of the cell. It means, however, that all enzymes beyond the entries function below their capacities, which might be interpreted as an uneconomic overproduction of enzymes. It also means, if the enzymes have the appropriate K, values, that labile intermediates can be present at extremely low concentrations in the cell. It happens that carbamoylphosphate, one of the substrates of ornithine transcarbamylase, and argininosuccinate, the substrate of argininosuccinase, are unstable compounds. 
